FDA Details Pathways For Speedier Drug Approvals
The U.S. Food and Drug Administration on Tuesday laid out criteria for a quartet of pathways providing speedier approval of medications designed to address unmet needs for serious conditions, building on...To view the full article, register now.
Already a subscriber? Click here to view full article